Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PAVmed Q3 Adj. EPS $(0.02) Beats $(0.20) Estimate, Sales $5.000K Miss $12.500K Estimate

Author: Benzinga Newsdesk | November 13, 2025 08:48am
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.20) by 90 percent. This is a 96.3 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $5.000 thousand which missed the analyst consensus estimate of $12.500 thousand by 60.00 percent. This is a 99.50 percent decrease over sales of $996.000 thousand the same period last year.

Posted In: PAVM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist